| 000 | 01777 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515114152.0 | ||
| 264 | 0 | _c20080425 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1538-7445 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-07-6597 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, Hong-Gyum | |
| 245 | 0 | 0 |
_aMitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. _h[electronic resource] |
| 260 |
_bCancer research _cApr 2008 |
||
| 300 |
_a2538-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aG1 Phase _xdrug effects |
| 650 | 0 | 4 |
_aHistones _xmetabolism |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aRibosomal Protein S6 Kinases, 90-kDa _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 700 | 1 | _aLee, Ki Won | |
| 700 | 1 | _aCho, Yong-Yeon | |
| 700 | 1 | _aKang, Nam Joo | |
| 700 | 1 | _aOh, Sang-Muk | |
| 700 | 1 | _aBode, Ann M | |
| 700 | 1 | _aDong, Zigang | |
| 773 | 0 |
_tCancer research _gvol. 68 _gno. 7 _gp. 2538-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-07-6597 _zAvailable from publisher's website |
| 999 |
_c17881044 _d17881044 |
||